The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Papillary (Chromophil) Renal Cell Carcinoma: Histomorphologic Characteristics and Evaluation of Conventional Pathologic Prognostic Parameters in 62 Cases
Abstract
For more than two decades, papillary renal cell carcinoma has been recognized as a possible distinct clinicopathologic subtype of renal cell carcinoma (RCC). However, the histologic criteria for its diagnosis and the clinical outcome are still debated. In an attempt to clarify the diagnostic criteria and resolve issues pertaining to biologic potential, we have evaluated the histologic spectrum of 62 papillary RCCs and assessed significance of conventional pathologic prognostic parameters (Fuhrrman's nuclear grade [NG], pathologic stage [Robson and TNM], tumor size, multifocality, necrosis, and foam cells) and correlated these with outcome. The mean age of patients was 61.8 years (range 22-83), and males were more commonly affected (1.8:1). Grossly, most tumors were well circumscribed, averaged 6.7 cm in size (range 1.8-18), and were predominantly localized to the renal poles (polar vs. mid-renal, 3:1). Multifocality was a prominent feature (24 cases), and in three cases tumors were bilateral. Microscopically, papillary RCCs were predominantly papillary or tubulopapillary, often with a thick fibrous capsule, foam cells, necrosis, hemorrhage, and multifocality. Thirty-five percent of these tumors were low grade (NG I and II) and 65% high grade (NG III and IV). Sixteen of these tumors presented in a higher stage (stages III and IV), and the overall stage correlated with NG (chi 2, p = 0.009). Tumors were further distinguished by cytoplasmic features: eosinophilic (42%), basophilic (34%) and mixed (24%). Eosinophilic tumors were predominantly high grade, and basophilic tumors low grade (chi 2, p = 0.000). A mean follow-up of 57 months showed progression (metastasis, recurrence, or death due to disease) in 21%, whereas 63% were free of disease. Eleven percent died of unrelated causes, and 5% were lost to follow-up. Kaplan-Meier survival analysis showed that both high NG and stage were strongly associated with decreased survival (p = 0.0000 each), as were decreased foam cell (p = 0.0025) and vascular invasion (p = 0.0002). Comparison of 196 reported cases of papillary RCC, including the current series, with reported large series of conventional RCC indicates that papillary RCC usually presents at an early stage, and stage I (Robson) papillary RCC has better 5 year survival rates (87%-100%) than does RCC of the same stage (65-75%). The overall 5 years survival rate for papillary carcinoma (82-90%) was also higher than that of conventional RCC (44-54%). In a Cox proportional hazard regression model, TNM stage appeared to be the only significant variable (p = 0.0000, hazard ratio 10.1) in predicting outcome among papillary RCC. Based on this experience, we conclude that (a) papillary RCC is a malignant tumor, with a tendency to present at a lower stage, but with a distinct potential for progression and aggressive behavior; (b) stratification of these tumors according to cell type, amount of foam cells, presence or absence of vascular invasion, nuclear grade, and pathologic stage provides useful prognostic information; (c) the better 5-year survival rate of papillary RCC (overall and for stage I tumors) compared with that of conventional RCC suggests that it is a tumor with lower malignant potential. Thus, histologic subcategorization of a renal carcinoma as papillary RCC appears to have prognostic implications.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prognostic significance of morphologic parameters in renal cell carcinoma
Fuhrman, S. A., Lasky, L. C., & Limas, C. (1982) · The American Journal of Surgical Pathology · doi:10.1097/00000478-198210000-00007 · Cited by 2,724
The Results of Radical Nephrectomy for Renal Cell Carcinoma
Robson, C. J., Churchill, B. M., & Anderson, W. (1969) · Journal of Urology · doi:10.1016/s0022-5347(17)62331-0 · Cited by 1,283
Histopathology and Classification of Renal Cell Tumors (Adenomas, Oncocytomas and Carcinomas)
Thoenes, W., Störkel, S., & Rumpelt, H. J. (1986) · Pathology - Research and Practice · doi:10.1016/s0344-0338(86)80001-2 · Cited by 664
Renal Medullary Carcinoma The Seventh Sickle Cell Nephropathy
Davis, C. J., Mostofi, F. K., & Sesterhenn, I. A. (1995) · The American Journal of Surgical Pathology · doi:10.1097/00000478-199501000-00001 · Cited by 599
Renal Cell Carcinoma: Long-Term Survival and Late Recurrence
McNichols, D. W., Segura, J. W., & DeWeerd, J. H. (1981) · Journal of Urology · doi:10.1016/s0022-5347(17)54359-1 · Cited by 495
Renal cell carcinoma: earlier discovery and increased detection.
Smith, S. J., Bosniak, M. A., Megibow, A. J., Hulnick, D. H., Horii, S. C., & Raghavendra, B. N. (1989) · Radiology · doi:10.1148/radiology.170.3.2644658 · Cited by 355
Chromophobe cell renal carcinoma and its variants—a report on 32 cases
Thoenes, W., Störkel, S., Rumpelt, H. ‐., Moll, R., Baum, H. P., & Werner, S. (1988) · The Journal of Pathology · doi:10.1002/path.1711550402 · Cited by 347
Cytogenetics of papillary renal cell tumors
Kovacs, G., Fuzesi, L., Emanuel, A., & Kung, H. (1991) · Genes, Chromosomes and Cancer · doi:10.1002/gcc.2870030403 · Cited by 320
Hereditary Papillary Renal Cell Carcinoma
Zbar, B., Tory, K., Merino, M., Schmidt, L., Glenn, G., Choyke, P., Walther, M. M., Lerman, M., & Linehan, W. M. (1994) · Journal of Urology · doi:10.1016/s0022-5347(17)35015-2 · Cited by 308
Corless, C. L., Aburatani, H., Fletcher, J. A., Housman, D. E., Amin, M. B., & Weinberg, D. S. (1996) · Diagnostic Molecular Pathology · doi:10.1097/00019606-199603000-00009 · Cited by 213
Self-citation
Cited by
The Somatic Genomic Landscape of Chromophobe Renal Cell Carcinoma
Davis, C. F., Ricketts, C. J., Wang, M., Yang, L., Cherniack, A. D., Shen, H., Buhay, C., Kang, H., Kim, S. C., Fahey, C. C., et al. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.07.014 · Cited by 842
Self-citationPrognostic Value of Histologic Subtypes in Renal Cell Carcinoma: A Multicenter Experience
Patard, J.-J., Leray, E., Rioux-Leclercq, N., Cindolo, L., Ficarra, V., Zisman, A., De La Taille, A., Tostain, J., Artibani, W., Abbou, C. C., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.07.055 · Cited by 754
SURGICAL MANAGEMENT OF RENAL TUMORS 4 CM. OR LESS IN A CONTEMPORARY COHORT
LEE, C. T., KATZ, J., SHI, W., THALER, H. T., REUTER, V. E., & RUSSO, P. (2000) · Journal of Urology · doi:10.1016/s0022-5347(05)67793-2 · Cited by 638
Use of Antibodies to RCC and CD10 in the Differential Diagnosis of Renal Neoplasms
Avery, A. K., Beckstead, J., Renshaw, A. A., & Corless, C. L. (2000) · The American Journal of Surgical Pathology · doi:10.1097/00000478-200002000-00006 · Cited by 360
Self-citationSolid Renal Cortical Tumors: Differentiation with CT
Zhang, J., Lefkowitz, R. A., Ishill, N. M., Wang, L., Moskowitz, C. S., Russo, P., Eisenberg, H., & Hricak, H. (2007) · Radiology · doi:10.1148/radiol.2442060927 · Cited by 310
Metadata
- Authors
- Amin, M. B., Corless, C. L., Renshaw, A. A., Tickoo, S. K., Kubus, J., & Schultz, D. S.
- Venue
- The American Journal of Surgical Pathology
- Published
- 1997-06
- Volume
- 21
- Issue
- 6
- Pages
- 621-635
- ISSN
- 0147-5185 (ISSN-L)
- OpenAlex
- W2033803003
- Cited by
- 335
- References
- 13
- FWCI
- 15.80
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Papillary (Chromophil) Renal Cell Carcinoma: Histomorphologic Characteristics and Evaluation of Conventional Pathologic Prognostic Parameters in 62 Cases. https://app.cochat.ai/papers/10.1097/00000478-199706000-00001
- The paper
- Amin, M. B., Corless, C. L., Renshaw, A. A., Tickoo, S. K., Kubus, J., & Schultz, D. S. (1997). Papillary (Chromophil) Renal Cell Carcinoma: Histomorphologic Characteristics and Evaluation of Conventional Pathologic Prognostic Parameters in 62 Cases. The American Journal of Surgical Pathology. https://doi.org/10.1097/00000478-199706000-00001
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.